Glutamate, the major transmitter of the corticostriatal pathway, is present in abundance in the striatum. 3-Hyclroxyanthranilic acid oxygenase (3HAO) is the biosynthetic enzyme for quinolinic acid, an endogenous agonist of the NMDA glutamate receptor subtype and a potent neurotoxin. In order to explore the anatomical basis of possible functional interactions between glutamate and quinolinic acid in the rat striatum, pre-and postembedding immunocytochemical methods were used to localize 3HA0 immunoreactivity (4) and glutamate-i at the electron microscopic level. In accordance with previous light microscopic and biochemical studies, 3HAO-i was detected exclusively in astrocytes throughout the striatum. Notably, BHAO-i was present in fine-caliber glial processes that often surrounded or abutted synaptic profiles, both asymmetric and symmetric. Glutamate-i was heavily deposited (3-13-fold higher gold particle density than tissue average) in axon terminals forming asymmetric synapses with spines and, occasionally, dendrites.
In The ubiquitous excitatory neurotransmitter glutamate plays a critical role in the normal function of the mammalian neostriaturn. A number of studies have established that striatal neuro-transmitter glutamate is derived largely from corticifugal striatal afferents. Thus, both glutamate content (Kim et al., 1977) and high-affinity glutamate uptake (Divac et al., 1977; McGeer et al., 1977) are reduced in the striatum following cortical ablation. Conversely, glutamate is released in the rat striatum during electrical stimulation of the cortex (Perschak and Cuenod, 1990) . Moreover, corticostriatal excitatory postsynaptic potentials are clearly mediated by excitatory amino acid (EAA) receptors (Herrling, 1985) , which have been identified and extensively characterized in the striatum (Monaghan and Cotman, 1985; Monaghan et al., 1989; Martin et al., 1992 Martin et al., , 1993 . Classical anatomical studies have demonstrated that striatal afferents originate largely from the cortex (Kemp and Powell, 197 1) and form asymmetric synapses onto striatal projection neurons (Pasik et al., 1980) . Finally, in ultrastructural studies using anti-glutamate antibody, glutamate has been localized in axon terminals which form asymmetric synapses in the striatum (Meshul et al., 1992; Snyder et al., 1993) . In addition to its physiological role in the striatum, glutamate has the potential to be excitotoxic, and thus may play a role in neurodegenerative brain disorders involving the striatum, such as Huntington's disease (HD) (Coyle and Schwartz, 1976; McGeer and McGeer, 1976) . However, when injected directly into the rat striatum, glutamate causes only very limited damage, even when administered at high concentrations , probably due to its effective removal from the synaptic cleft (Drejer et al., 1982; Fonnum, 1984; Erecifiska and Silver, 1990) . The most potent endogenous excitotoxin discovered so far is quinolinic acid (QUIN), a selective N-methyl-oaspartate (NMDA) receptor agonist (Stone and Perkins, 1981; Wolfensberger et al., 1983) which readily produces axon-sparing neuronal destruction in the rat striatum . Since QUIN-induced striatal lesions mimic many of the neuropathological features of HD Beal et al., 1986; Roberts et al., 1993 ) QUIN has been implicated in the neurodegeneration occurring in HD. The enzyme directly responsible for the synthesis of QUIN, 3-hydroxyanthranilic acid oxygenase (3HAO), is present in brain tissue (Foster et al., 1986) , and its activity is substantially elevated in the brain of HD victims . Rat 3HA0 has been purified from liver and brain, and anti-3HA0 antibodies have been produced and used for the immunocytochemical localization of 3HA0 in the rat brain . Studies at the light microscopic level, which included double labeling with antibod-ies against glial fibrillary acidic protein (Kijhler et al., 1988a) , showed that the enzyme is contained in astrocytes throughout the adult rat brain including the striatum.
The available data therefore suggest an involvement of NMDA receptors in normal and perhaps in abnormal striatal function, and a role of QUIN in the modulation of striatal NMDA receptors in healthy and diseased states. The aim of the present study was to examine the relationship between glutamate immunoreactivity (-i) and 3HAO-i in the adult rat striatum at the electron microscopic level. Particular attention was paid to the relationship between 3HAO-i processes and synaptic profiles involving glutamate-labeled axon terminals. A preliminary report of this work has been published in abstract form (McCarthy et al., 1993) .
Materials and Methods Animals
Twenty-eight adult Sprague-Dawley rats (20@220 gm) were deeply anesthetized with a mixture of xylazine/ketamine (1 mg xylazine + 5 mg ketamine/lOO gm body weight) and perfused through the heart with 50 ml saline followed by 350 ml of fixative containing (1) 4% paraformaldehyde, 0.03 M periodate, and 0.1 M lysine in 0.1 M phosphate buffer (PB), pH 7.4 (McLean and Nakane, 1974) (n = 17); (2) l-1.5% glutaraldehyde and 14% paraformaldehyde in 0.1 M PB, pH 7.4 (n = 10); or (3) 2.5% glutaraldehyde and 1% paraformaldehyde in 0.1 M PB, pH 7.4 (n = 1). The brains were postfixed for 3 hr in the same fixative, stored in PB for 2-24 hr (4"(Z), and sectioned with a cryostat (20 pm thick) or a vibratome (40 pm thick). Coronal sections throughout the rostrocaudal extent of the striatum were collected and one series of sections out of six was processed for immunocytochemistry.
Localization of 3HAO-i using pre-embedding techniques As described previously, 3HA0 was purified to homogeneity from liver, and liver and brain 3HA0 were confirmed to be identical using a spectrum of biochemical, physicochemical, and immunological techniques .
Sections were processed for the immunocytochemical localization of rabbit anti-3HA0 antibody, according to a modification of the pre-embedding protocol of Kohler et al. (1987) . Briefly, free-floating sections from rats perfused with fixative 1 (n = 17) or 2 (n = 8) and cut with the cryostat (n = 7) or vibratome (n = 18) were incubated in 2% normal goat serum in PB for 30 min prior to incubation in anti-3HA0 (1:3000) for 72 hr (4°C). Sections were then processed using reagents from the avidin-biotin kit using recommended dilutions (Hsu et al., 1981) , followed by reaction with diaminobenzidine (6 mg/lO ml PB) containing 0.03% hydrogen peroxide for 5-15 min. Tissue cut on the cryostat was mounted on gelatin-coated slides and coverslipped, whereas tissue cut on the vibratome was prepared for electron microscopic analysis (see below).
Preparation of tissue for electron microscopy
Tissue sections from all brains cut on the vibratome were processed for electron microscopy. (1) Tissue processed for 3HAO-i (fixative 1) was embedded using standard techniques. Briefly, sections were immersed in 1% osmium tetroxide for 1 hr, stained with 1% uranyl acetate for 1 hr, dehydrated in alcohols, embedded flat in Epon, and-heated at 60°C for 72 hr. (2) To nrenare tissue for uostembedding immunolabeling with anti-glutamate antibody, tissue processed for 3HAO-i (fixative-2) or unprocessed tissue (fixative 3) was embedded using the following protocol. Sections were immersed in 1% osmium tetroxide for 1 hr, dehydrated with a series of alcohol dilutions, flat embedded in Durcupan ACM resin, and heated at 56°C for 48 hr. Areas from the striatum containing optimal 3HA0 staining or random areas in unstained tissue were excised, mounted on Epon blocks, and thin (90 nm) sectioned. Thin sections were collected onto Formvar-coated slot grids (for single label analysis of 3HAO-i) or nickel mesh grids (for the postembedding immunogold procedure).
Localization of glutamate using postembedding techniques
Striatal tissue sections were processed using a modification of the procedure of Somogyi and Hodgson (1985) . The sections, collected on nickel mesh grids and dried overnight at 50°C were immersed sequentially in the following solutions: (1) 1% periodic acid (HIO,) in doubledistilled water (ddW) for 7 min; (2) 8% sodium m-periodate (NaIO,) in ddW for 15 min; (3) 1% human serum albumin (HSA) in ddW for 10 min; (4) 1% HSA in Tris phosphate-buffered saline (TPBS, 0.4 gm KCl, 0.2 gm NaN,, 7.0 gm NaCl per liter of 0.01 M PB + 0.01 M Tris/ HCl) for 10 min; (5) glutamate antiserum (#607; diluted 1: lOO-1:900 in TPBS containing 2% HSA and preadsorbed with 100 pM aspartateglutaraldehyde complex, 200 FM glutamine-glutaraldehyde complex, and 200 PM P-alanine-glutaraldehyde complex) for 2 hr Broman et al., 1993) ; (6) 1% HSA in TPBS for 10 min; (7) 0.05 M Tris and 0.5 mg/liter polyethyleneglycol in ddW ("Tris buffer") for 3 min; and (8) colloidal gold (20 nm) coupled to anti-rabbit IgG (diluted 1:20 in Tris buffer) for 2 hr. All steps were followed with thorough rinses in either ddW or TPBS. After drying, the sections were stained with 1% uranvl acetate (23 min) and 0.3% lead citrate (3 min). The tissue sections were incubated together with test sections carrying a series of different amino acid conjugates for continuous monitoring of specificity.
Quantitative ultrastructural analysis Analysis of 3HAO-i. Electron micrographs were taken at a magnification of 15,000X and were analyzed at a final magnification of 30.000~. Ten fields from the striatum were photographed per rat (six animals perfused with fixative 1) near the edge of the tissue, where immunoreactivity was present but background staining was minimal. All synapses were counted, and the proportion of synapses in each field that had immunoreactive glial processes in direct contact with synaptic profiles, either adjacent to or surrounding the synaptic profiles, was determined. 3HAO-i profiles were deemed adjacent if they were directly adjacent to one or both synaptic profiles. 3HAO-i profiles were judged to surround synaptic profiles if they encircled at least 50% of the circumference of the synaptic profiles including the region of the synapse.
Analysis of glutamate-i. Electron micrographs were taken from single-and double-labeled material at a magnification of 17,000X, and analyzed at 34,000X. Ten fields from the striatum were photographed per rat (six animals perfused with fixative 2 and one animal perfused with fixative 3). The distribution of glutamate-i was analyzed using SIGMA-SCAN software to quantify the number of colloidal gold particles per square micron in the following profiles: axon terminals forming asymmetric synapses; axon terminals forming symmetric synapses; astrocytic processes; dendrites and the lumen of capillaries. Axon terminals forming asymmetric synapses were not subdivided according to subtypes of Hassler et al. (1978) . Gold particle density values do not include mitochondrial labeling. Group means were compared using an independent Student's t test. A Bonferroni correction was used to correct for multiple comparisons.
Controls
Controls consisted of (1) omitting the 3HA0 antibody, (2) preadsorbing the 3HA0 antibodv with 31 ~*.g oure 3HA0 ner 1 ml diluted antibodv for 24 hr ,73) preadsorbing the glutamate antibod; with 300 yM of glutamate-glutaraldehyde complex ) and (4) exoosine tissue labeled with 3HA0 antibodies to naraformaldehyde'fumes pryor to incubation with glutamate antibody &de-nature free rabbit anti-IgG sites (Wang and Larsson, 1985; . This final control was necessary to avoid interference between the first and second incubations because both antibodies were produced in rabbit. Therefore, the possibility existed in double-labeled material that the secondary antibody in the glutamate protocol (colloidal gold conjugated anti-rabbit IgG) would attach to free 3HA0 IgG sites, producing a certain amount of nonspecific gold labeling in astrocytic processes (the only cellular compartment we measured where both 3HA0 and glutamate are present).
Results

3HA0 immunoreactivity
At the light microscopic level, 3HAO-i was detected in glial cells which appeared to be homogeneously distributed throughout the striatum (Fig. IA) . Immunoreactivity was present in the cell bodies of astrocytes, in their widely ramifying proximal processes, and in an intricate network of fine-caliber processes (Fig.  1C) . Utilizing the present methods, 3HAO-i was not detected in Roberts et al. l @, fiber bundle (B, C). Scale bars: A, 1000 pm; B and C, 100 pm. astrocytes in the white matter, though preliminary results using a more sensitive technique (Adams, 1992) indicate the presence of some labeled astrocytes in white matter. This apparent difference in staining intensity may be related to heterogeneous features of astrocytes in gray and white matter (Miller and Raff, 1984; Shehab et al., 1990) . The pattern of immunoreactivity was virtually identical between cryostat and vibratome sections. Immunolabeling of the tissue from rats prepared with fixative 1 was superior to that from tissue prepared with fixative 2 in that more extensive staining of processes was achieved. Specific staining was eliminated by the preadsorption control in sections cut on the cryostat (Fig. 1B) and vibratome (not shown).
Confirming our light microscopic observations, 3HAO-i was detected exclusively in the cell bodies and processes of astrocytes (Fig. U-C) . All immunoreactive astrocytes exhibited cytoplasmic labeling (Fig. U-C) , which was deposited diffusely on various organelles including rough endoplasmic reticulum, fibrils, and some outer mitochondrial membranes (Fig. 2C) . Moreover, nuclear labeling was also detected in a subset of immunoreactive astrocytes (Fig. 2B,C) . Immunoreactive processes emanated from the astroglial somata ( Fig. 2A) and were also abundant throughout the neuropil in small-caliber processes (Fig. 3A-C) , which partially engulfed synaptic profiles (Fig.  3B,C) . Several types of synaptic profile, including asymmetric axospinous and axodendritic (Fig. 3) , symmetric axodendritic (see Fig. 5 ) and symmetric axospinous synapses (not shown), were contacted or encircled by labeled glial profiles.
Quantification of 3HAO-labeled astrocytic processes and synaptic profiles is summarized in Table 1 . Approximately 36% of asymmetric and 29% of symmetric synapses formed between terminals and either spines or dendrites were closely associated with (i.e., adjacent to or surrounded by) a 3HAO-labeled glial process. Therefore, 3HAO-i processes do not appear to be preferentially related to either type of synapse. Taken together, 35% of all synapses (excluding axosomatic, which were not tabulated) were contacted by 3HAO-containing processes.
Glutamate immunoreactivity Glutamate-i was deposited throughout the neuropil in varying densities in several types of subcellular profiles including axon terminals, dendrites, spines, neuronal somata, astrocytes, and astrocytic processes (Fig. 4) . Based on qualitative inspection, the density of gold particles was much higher in terminals forming asymmetric synapses than in other cellular profiles. However, even in areas exhibiting maximal labeling, some terminals forming asymmetric synapses did not contain a high density of gold particles. Nevertheless, within axon terminals forming asymmetric synapses, gold particles were overlying or closely associated with synaptic vesicles. Within most cellular profiles (except spines which lack mitochondria), gold particles were often associated with mitochondria. Specific staining was eliminated with the glutamate preadsorption control (not shown). Specificity of staining was verified using test sections that accompanied the tissue sections, as described in Ottersen et al. (1992) . Quantification of glutamate labeling in cellular profiles is summarized in Table 2 . The density of gold particles in terminals forming asymmetric synapses was significantly higher than in other subcellular domains, confirming our qualitative observations. This relationship was verified in each of the seven individual animals studied. Moreover, when the data were pooled, the mean gold particle density in axon terminals forming asymmetric synapses was significantly higher than in other subcellular compartments. Ratios of the number of gold particles in terminals forming asymmetric synapses compared to other cellular profiles are presented in Table 3 . These ratios ranged from 3.2:1 to 13.5: 1, indicating higher binding of glutamate in axon terminals forming asymmetric synapses as compared with other profiles.
Double labeling with 3HA0 and glutamate antibodies
In double-labeled material, 3HAO-i was found predominantly in large-caliber processes and, less frequently than in the singlelabeled tissue, in fine astrocytic processes (Fig. 5A-D) . The compromised immunoreactivity was due to the high glutaraldehyde concentration in the fixative which was necessary to obtain specific glutamate staining. Nevertheless, 3HAO-labeled Figure 4 . Electron micrographs of glutamate-i in striatal neuropil. Glutamate-i was deposited in various cellular profiles with varying intensity. It was most heavily deposited (2-14-fold higher gold particle density than tissue average; see Table 3 ) in axon terminals (at) forming asymmetric synapses (arrows) with spines (s). A, Field of neuropil showing several synapses. Fixative 2. B and C, Higher-magnification views of individual labeled glutamatergic axon terminals forming synapses (fixative 3). g, glial process. Scale bars, 0.5 p,m. processes, albeit large, were found adjacent to or abutting synaptic profiles, many of which were glutamate containing (Fig.  5 ). Thus, 3HAO-i astrocytic processes were most frequently encountered adjacent to asymmetric synapses formed between spines and axon terminals heavily labeled by the glutamate antibody. 3HAO-i processes were also found adjacent to symmetric synapses formed between dendrites and glutamate-negative axon terminals (Fig. 5A) , though the number of such appositions was low due to the scarcity of symmetric synapses.
Discussion
The main results of the present study are the following: (1) 3HAO-i is abundant throughout the rat striatum in astrocytic cell bodies and in an extensive network of fine-caliber processes which encircles synaptic profiles; (2) glutamate-i is distributed in various cellular profiles throughout the striatum, but is most heavily deposited in axon terminals forming asymmetric synapses; and (3) 3HAO-containing astrocytic processes are frequently found in close apposition to glutamate-containing terminals forming asymmetric synapses.
The demonstration of 3HA0 in striatal astrocytes is consistent KGhler et al., 1988a,b; Schwartz and Du, 1991) . Although 3HAO-i astrocytes appear to constitute a homogeneous population at the light microscopic level, two subtypes can be distinguished by electron microscopy, based on the presence or absence of nuclear staining. While poorly understood, the nuclear labeling is clearly not unspecific since it was found only in cells that also showed cytoplasmic labeling. Notably, striatal 3HAO-i is remarkably pervasive, particularly in fine processes encircling synapses. The close relationship between 3HAO-labeled processes and synaptic profiles may be a common feature of most brain structures. For example, the striaturn appears to have a similar proportion of synaptic profiles in contact with 3HAO-i processes as the substantia nigra pars compacta, the only other brain area where an ultrastructural analysis of the anatomical features of 3HAO-i elements and their microenvironment has been performed to date (Roberts et al., in press ). However, it is our impression that the proportion of total synaptic profiles surrounded, rather than abutted, by 3HAO-i 
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processes is lower in the striatum than in the substantia nigra pars compacta.
The results of the experiments with the anti-glutamate antibody provide a quantitative description of the subcellular distribution of glutamate in the striatum, and are consistent with current concepts regarding the nature and function of the striatal glutamatergic system (see introductory remarks). Thus, striatal profiles containing the most intense glutamate labeling were axon terminals forming asymmetric synapses, typical of cortical and thalamic input (Kemp and Powell, 1971 ). In agreement with previous studies in the hippocampus and the cerebellum, many gold particles in boutons were associated with synaptic vesicles (Somogyi et al., 1986; Broman and Ottersen, 1992; . Consistent with the fact that glutamate also exists in nontransmitter pools, for example, as a participant in intermediary metabolism (Fonnum, 1984) , glutamate labeling was also observed in several other subcellular compartments. For example, glutamate is transported into mitochondria (Dennis et al., 1976; Minn and Gayet, 1977) , the primary site of glutamate synthesis by phosphate-activated glutaminase (Salganicoff and DeRobertis, 1965; Erecihska and Silver, 1990) ; accordingly, mitochondrial profiles were moderately to heavily labeled. Astrocytes, which actively accumulate glutamate (Drejer et al., 1982; Fonnum, 1984) , possessed lower intensities of glutamate labeling than axon terminals forming asymmetric synapses (Ottersen et al., 1992 and references therein) .
As a selective yet rather weak NMDA receptor agonist (Stone and Perkins, 1981) , QUIN can be expected to affect NMDA receptors provided that its synaptic concentrations are sufficiently high. The concentration of lo-20 nM, which is usually given based on QUIN measurements in cerebrospinal fluid (Moroni et al., 1986; Schwartz et al., 1988b; Heyes et al., 1991) or brain microdialysates (During et al., 1989; Speciale et al., 1989) , has been repeatedly judged to be too low for receptor activation, which reportedly requires at least 1000 times more QUIN (Martin and Lodge, 1987; Peters and Choi, 1987) . 3HAO-labeled astrocytic processes were found to be in close apposition to asymmetric synapses which typically mediate glutamatergic neurotransmission, as well as with symmetric synapses which are preferentially linked to inhibitory neurotransmission (Ribak et al., 1979) . These anatomical arrangements imply that discrete synaptic QUIN concentrations may in fact exceed previous estimates, and suggest a role of QUIN as an endogenous participant in NMDA receptor function and dysfunction in the rat striaturn. Notably, neostriatal neurons, including medium-sized and large cells, contain the NMDARl receptor subunit (Petralia et al., 1994) and the mRNA encoding the NMDA receptor (Ge et al., 1992) . It is therefore certainly possible that striatal synapses engulfed by QUIN-producing processes carry functional NMDA receptors. Colocalization of the NMDA receptor and 3HA0 at the ultrastructural level is currently underway in our laboratories.
In spite of the anatomical features of QUIN-producing astrocytes, which are suggestive of a role of QUIN in glutamatergic transmission in the striatum, definitive proof of such a role will have to await a better understanding of QUIN neurobiology in the normal and abnormal brain. For example, while it has been established that astrocytes have a limited capacity to store newly synthesized QUIN and are capable of releasing QUIN into the extracellular compartment (Speciale and Schwartz, 1993) , the metabolic control of brain 3-hydroxyanthranilic acid, the substrate of 3HA0, has so far not been elucidated. Moreover, the function of the QUIN-degrading enzyme quinolinic acid phosphoribosyltransferase, which is also largely contained in astrocytes (Kiihler et al., 1987; Du et al., 1991) , has not been clarified to date. Eventually, relevant information is expected to come from studies using selective pharmacological agents such as 3HA0 inhibitors (Walsh et al., 1991 (Walsh et al., , 1994 .
The astrocytic localization of 3HA0 is in agreement with biochemical studies which have shown large increases in 3HA0 activity following destruction of neurons in rats (Speciale et al., 1987; Schwartz et al., 1989; Saito et al., 1993) or in HD . Thus, the increased production and release of QUIN in lesioned tissue, which has been verified directly in neuron-depleted striatal slices (Speciale and Schwartz, 1993) , is likely due to the astrogliotic reaction to neurodegeneration (Bjorklund et al., 1986) . Although alternative interpretations regarding the lesion-induced increase in QUIN production, and of the cellular source of brain QUIN in general, have been purported (Moffett et al., 1993; Saito et al., 1993) , recent ultrastructural studies of 3HAO-i in the excitotoxin-lesioned rat striaturn have confirmed the prominent location of the enzyme in normal and reactive astrocytes (McCarthy et al., 1993) .
While the QUIN model of HD, effected by acute or subchronic (DiFiglia, 1990; Bazzett et al., 1993) intrastriatal injection of the toxin into experimental animals, has been widely used, arguments have been raised against the proposition that a pathological overabundance of endogenous QUIN is causally involved in the neurodegenerative process. Thus, in spite of increased 3HA0 activity in the HD brain, which is particularly prominent in the basal ganglia (Schwartz et al., 1988) , QUIN levels measured in brain tissue homogenates (Reynolds et al., 1988) or cerebrospinal fluid are not elevated in HD and in fact show a tendency to decrease (Heyes et al., 1991) . In light of the physical proximity of QUIN-pro- Roberts et al. l 3HA0 and Glutamate Localization i n Rat Striatum Figure   5 . Several examples of striatal neuropil double labeled with antibodies against 3HA0 and glutamate (fixative 2). 3HAO-labeled glial processes (g) are adjacent to glutamate-labeled axon terminals (at) forming asymmetric synapses (solid arrows) with spines (s). A, Glutamate-i axon terminals forming asymmetric synapses are abutted by 3HAO-i glial processes. Note the presence of an unlabeled terminal (*) forming a symmetric synapse (arrowhead) with a dendrite. The open arrow indicates a thin SHAO-i glial process. B-D, Glutamate-i terminals forming asymmetric synapses abutted or partially surrounded by SHAO-i glial processes (fixative 2). (Note that fixative containing glutaraldehyde is necessary for glutamate immunocytochemistry, but results in the confinement of 3HA0 labeling mainly to large-caliber glial processes, though fine 3HAO-i processes can be occasionally detected). Scale bars, 0.5 pm. ducing astrocytic processes and glutamatergic synapses, it now seems prudent to view the putative neurotoxic roles of QUIN and glutamate in tandem; that is, to study the possible functional interdependence of the classical neurotransmitter glutamate and astrocyte-derived QUIN (Fig. 6) . Synergism between these two excitatory amino acid receptor agonists has been demonstrated in hypoxic hippocampal slices (Schurr and Rigor, 1993) , and similar scenarios, involving interactions at and beyond the NMDA recognition site, can be envisioned to play a role in HD neurodegeneration. Moreover, it may be of significance that kynurenine aminotransferase, the biosynthetic enzyme for the endogenous neuroprotectant kynurenic acid, too, is localized in astrocytic processes adjacent to asymmetric striatal synapses (Roberts et al., 1992) . Therefore, potential interactions at the synaptic level of glutamate, QUIN, and kynurenic acid, a broadspectrum glutamate receptor antagonist, must be considered with regard to the occurrence or prevention of neuronal damage. More generally, such mechanisms may constitute a conceptual modification of classic excitotoxic theory and could be applicable to a spectrum of neurodegenerative brain diseases.
